Immediate Impact
1 from Science/Nature 70 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of Ewa Surmiak being referenced
A therapeutic patent overview of MDM2/X-targeted therapies (2014–2018)
2019
Helping the Released Guardian: Drug Combinations for Supporting the Anticancer Activity of HDM2 (MDM2) Antagonists
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ewa Surmiak | 203 | 188 | 123 | 22 | 365 | |
| Zilun Hu | 160 | 123 | 128 | 21 | 407 | |
| Betsy S. Pierce | 216 | 75 | 164 | 14 | 401 | |
| Keiko Tsuganezawa | 205 | 66 | 109 | 20 | 324 | |
| Rachel C. Botham | 214 | 66 | 151 | 15 | 405 | |
| V. F. Pozdnev | 227 | 56 | 114 | 37 | 356 | |
| Parima Udompholkul | 268 | 122 | 204 | 19 | 398 | |
| Hossam Nada | 205 | 81 | 153 | 35 | 388 | |
| Rich Woessner | 159 | 125 | 82 | 17 | 311 | |
| Hung V. Le | 259 | 104 | 61 | 12 | 365 | |
| Sei Yoshida | 268 | 111 | 79 | 22 | 363 |
All Works
Login with ORCID to disown or claim papers
Loading papers...